Derivative exercise or conversion — not an open-market buy.
Traded Jan 20, 2026 · Filed Jan 21, 2026
The money chief of Hims & Hers Health sold $275K of Hims & Hers Health shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$275,114
Shares × reported transaction price
78 days after results of Nov 3, 2025, 34 days before results of Feb 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −2.1% | +0.7% | −2.9% |
| 30 days | −49.2% | −1.0% | −48.2% |
| 90 days | −5.0% | +3.2% | −8.2% |
| 180 days | +7.2% | +8.6% | −1.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
CFO sold ~$139K of Hims & Hers Health
Automatic saleDerivative exercise or conversion — not an open-market buy.